Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection with Chlamydia pneumoniae in Brooklyn.

K Chirgwin1, P M Roblin, M Gelling

  • 1Department of Medicine, State University of New York Health Sciences Center, Brooklyn.

The Journal of Infectious Diseases
|April 1, 1991
PubMed
Summary

Chlamydia pneumoniae caused lower respiratory tract infections in 18.7% of patients, being more common in adults. Its role in pneumonia and chronic carriage requires further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae is a pathogen implicated in respiratory infections.
  • Understanding its prevalence and clinical significance in lower respiratory tract infections (LRTI) is crucial.

Observation:

  • 18.7% of 91 patients with LRTI showed evidence of Chlamydia pneumoniae infection.
  • Infection was more prevalent in older adolescents and adults compared to children.
  • Serologic evidence of acute infection was limited in culture-positive cases.

Findings:

  • Chlamydia pneumoniae infection presented with varied patterns, from acute pneumonia to asymptomatic carriage.
  • Coinfection with other bacterial pathogens was observed, potentially causing acute pneumonia episodes.

Related Experiment Videos

  • Some patients exhibited prolonged Chlamydia pneumoniae positivity over 12 months.

    • Implications:

    • The clinical presentation of Chlamydia pneumoniae LRTI is not distinct.
    • Further research, including studies on asymptomatic populations, is needed to clarify the epidemiology and clinical relevance of Chlamydia pneumoniae.
    • Diagnostic strategies may need refinement to accurately detect Chlamydia pneumoniae in respiratory infections.